ImmunityBio Income Statement (2014-2026) | IBRX

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.07M0.39M0.01M0.04M0.12M0.07M0.36M0.04M0.08M0.14M0.04M1.05M6.11M7.55M16.52M26.43M32.06M38.28M44.21M51.24M
Cost of Revenue (Quarter)
0.06M0.14M0.18M0.38M0.24M0.30M
Gross Profit (Quarter)
0.04M0.08M0.14M0.04M1.05M6.11M7.55M16.46M26.29M31.88M37.90M43.97M50.94M
Operating items
Research & Development (Quarter)
49.28M51.75M55.38M63.08M71.61M58.08M79.26M53.17M48.40M-178.83M0.60M0.30M0.70M0.60M0.60M0.10M0.60M60.82M
Selling, General & Administrative (Quarter)
29.62M27.91M40.61M16.57M19.31M26.21M32.68M32.02M31.82M-96.51M0.40M0.68M35.92M-122.52M0.50M0.30M0.60M-106.52M1.10M51.82M
Other Operating Expenses (Quarter)
-6.77M7.52M-36.95M43.47M-42.58M1.17M-1.17M-0.19M-236.62M-95.96M
Operating Expenses (Quarter)
78.90M79.66M95.99M79.66M90.92M84.97M111.94M85.19M80.22M85.53M95.24M100.38M86.36M76.95M80.95M97.71M87.69M102.97M114.00M112.94M
Operating Income (Quarter)
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
EBIT (Quarter)
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
Non-operating items
Non Operating Investment Income (Quarter)
-5.94M-6.93M1.67M-1.80M0.86M-3.81M0.67M-0.06M0.04M0.48M3.10M1.89M1.80M1.19M0.89M1.15M2.07M2.30M2.31M3.15M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.04M-0.06M-0.00M0.18M0.01M-0.19M-1.08M-2.22M-0.02M-0.02M0.01M-20.10M5.58M1.93M0.29M6.90M1.11M-0.69M
Non Operating Income (Quarter)
-9.59M-12.28M-7.03M-15.21M-20.36M-23.39M-5.00M-53.07M-15.51M-148.06M-38.93M-35.25M-5.50M10.22M-65.47M-21.02M-11.68M2.59M-563.00M-168.69M
Net income details
EBT (Quarter)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.29M-116.58M-138.21M-95.64M-233.45M-134.13M-134.58M-85.75M-59.18M-129.90M-92.31M-67.31M-62.09M-632.79M-230.39M
Tax Provisions (Quarter)
0.00M0.03M-0.04M-0.23M0.27M-0.14M0.01M
Profit After Tax (Quarter)
-88.43M-94.32M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.58M-233.39M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.25M-61.88M-632.78M-230.39M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
-0.80M-0.29M-0.17M-0.25M-0.22M-0.11M-0.24M-0.33M-0.06M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.01M-0.01M-0.01M
Income from Continuing Operations (Quarter)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.31M-61.96M-632.79M-230.39M
Consolidated Net Income (Quarter)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.31M-61.96M-632.79M-230.39M
Income towards Parent Company (Quarter)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.31M-61.96M-632.79M-230.39M
Net Income towards Common Stockholders (Quarter)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.31M-61.96M-632.79M-230.39M
Additional items
EPS (Basic) (Quarter)
-0.23-0.24-0.26-0.24-0.28-0.27-0.27-0.32-0.19-0.46-0.20-0.20-0.12-0.08-0.15-0.10-0.07-0.07-0.62-0.22
EPS (Diluted) (Quarter)
-0.23-0.24-0.26-0.24-0.28-0.27-0.27-0.32-0.19-0.46-0.20-0.20-0.12-0.08-0.15-0.10-0.07-0.07-0.62-0.22
Shares Outstanding (Quarter)
391.85M389.23M397.88M397.99M400.06M399.90M428.38M437.46M498.38M508.64M672.83M686.94M695.89M697.31M853.16M888.22M946.60M919.86M1,026.87M1,050.07M
Shares Outstanding (Diluted) (Quarter)
391.85M389.23M397.88M397.99M400.06M399.90M428.38M437.46M498.38M508.64M672.83M686.94M697.96M700.44M853.16M888.22M946.60M919.86M1,026.87M1,050.07M
Shares Outstanding (Entity) (Quarter)
394.51M397.83M397.96M398.07M400.30M435.92M435.92M440.67M498.38M508.64M677.00M691.79M696.83M697.31M853.56M915.63M984.97M1,011.80M1,047.34M1,053.22M
EBITDA (Quarter)
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
Interest Expenses (Quarter)
3.61M4.49M8.49M9.70M16.76M-18.65M29.82M32.23M35.02M0.40M29.46M29.79M29.32M26.02M15.59M15.47M15.26M14.84M77.07M100.93M
Tax Rate (Quarter)
0.00%-0.03%0.02%0.18%-0.29%0.22%0.00%